Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.99 USD | +3.37% | -2.92% | +30.82% |
Evolution of the average Target Price on G1 Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering G1 Therapeutics, Inc.
Wedbush | |
Needham & Co. | |
JPMorgan Chase | |
Raymond James | |
HC Wainwright | |
EF Hutton | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- GTHX Stock
- Consensus G1 Therapeutics, Inc.